AA
TMO icon

Antipodean Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Antipodean Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-529,000
Closed -$44.8M – 39
2013
Q2 		$44.8M Buy
+529,000
New +$44M 4.7% 7

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Antipodean Advisors's TMO Position: Q3 2013 in Review

Antipodean Advisors sold out of Thermo Fisher Scientific (TMO) in Q3 2013, closing a stake of 529,000 shares — an estimated $44.8M sold.

Antipodean Advisors first reported a position in TMO in Q2 2013 and held it in 1 quarter. The position peaked at $44.8M in Q2 2013. 817 funds tracked by Wall St. Rank hold TMO as of Q3 2013.

  • Antipodean Advisors reported no remaining Thermo Fisher Scientific position as of Q3 2013 after selling out during the quarter.
  • Antipodean Advisors sold 529,000 Thermo Fisher Scientific shares in Q3 2013, an estimated $44.8M.
  • Antipodean Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 1 quarter.
  • Antipodean Advisors's Thermo Fisher Scientific position peaked at $44.8M in Q2 2013.
  • 817 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2013.

Based on Antipodean Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.